Sandu Pharma.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE751D01014
NSEID:
BSEID: 524703
View on BSE

INR

34.80

-0.22 (-0.63%)

BSENSE

Feb 13

BSE+NSE Vol: 1.06 k

{
  "main_header": {
    "sid": 764862,
    "name": "Sandu Pharma.",
    "stock_name": "Sandu Pharma.",
    "full_name": "Sandu Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/sandu-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "34.80",
    "chg": -0.22,
    "chgp": "-0.63%",
    "dir": -1,
    "prev_price": "35.02",
    "mcapval": "34.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524703,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE751D01014",
    "curr_date": "Feb 13",
    "curr_time": "",
    "bse_nse_vol": "1.06 k",
    "exc_status": "Active",
    "traded_date": "Feb 13, 2026",
    "traded_date_str": "2026 02 13",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sandu-pharma-764862-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Sandu Pharmaceuticals Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sandu-pharmaceuticals-ltd-fallingrising-3829308",
        "imagepath": "",
        "date": "2026-02-10 00:13:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Volatility</strong></p>\n<p>Sandu Pharmaceuticals opened the trading session with a gap up of 3.52%, signalling early buying interest. Throughout the day, the stock exhibited high volatility, with an intraday price range of ₹4.06 and a peak intraday high of ₹37.96, representing a 12.24% surge from the previous close. Despite this wide trading range, the weighted average price indicates that a larger volume of shares exchanged hands closer to the lower end of the day’s price spectrum, suggesting some profit-taking or cautious trading among investors.</p>\n<p>The stock’s intraday volatility, calculated at 5.65%, underscores the heightened price fluctuations experienced during the session. This level of volatility is significant for a pharmaceutical stock and may reflect..."
      },
      {
        "title": "Sandu Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sandu-pharmaceuticals-ltd-is-rated-strong-sell-3825794",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SanduPharmaceut_mojoScore_3825794.png",
        "date": "2026-02-07 10:10:19",
        "description": "Sandu Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 September 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 February 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Sandu Pharmaceuticals Ltd Falls to 52-Week Low of Rs.35.11",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sandu-pharmaceuticals-ltd-falls-to-52-week-low-of-rs3511-3798859",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SanduPharmaceut_priceRelatedfactors_3798859.png",
        "date": "2026-01-21 12:15:24",
        "description": "Sandu Pharmaceuticals Ltd has reached a new 52-week low of Rs.35.11, marking a significant decline amid broader market pressures and company-specific performance issues. The stock has underperformed its sector and benchmark indices, reflecting ongoing challenges in growth and profitability metrics."
      },
      {
        "title": "Sandu Pharmaceuticals Ltd Falls to 52-Week Low Amid Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sandu-pharmaceuticals-ltd-falls-to-52-week-low-amid-continued-underperformance-3798856",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SanduPharmaceut_priceRelatedfactors_3798856.png",
        "date": "2026-01-21 12:14:55",
        "description": "Sandu Pharmaceuticals Ltd’s stock declined to a fresh 52-week low of Rs.35.8 on 21 Jan 2026, marking a significant milestone in its ongoing downward trajectory. The stock has underperformed both its sector and broader market indices, reflecting persistent challenges in its financial and market performance."
      },
      {
        "title": "Sandu Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sandu-pharmaceuticals-ltd-is-rated-strong-sell-3792887",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SanduPharmaceut_mojoScore_3792887.png",
        "date": "2026-01-15 10:10:03",
        "description": "Sandu Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 September 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Sandu Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sandu-pharmaceuticals-ltd-is-rated-strong-sell-3771273",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SanduPharmaceut_mojoScore_3771273.png",
        "date": "2025-12-26 15:12:03",
        "description": "Sandu Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 September 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 December 2025, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Sandu Pharmaceuticals Falls to 52-Week Low of Rs.36.76 Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sandu-pharmaceuticals-stock-falls-to-52-week-low-of-rs3676-3756336",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SanduPharmaceut_priceRelatedfactors_3756336.png",
        "date": "2025-12-11 10:00:18",
        "description": "Sandu Pharmaceuticals has reached a new 52-week low of Rs.36.76, marking a significant decline in its stock price amid ongoing challenges in its financial performance and market positioning within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Sandu Pharma. Sees Revision in Market Evaluation Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sandu-pharma-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3750189",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SanduPharma_mojoScore_3750189.png",
        "date": "2025-12-07 10:10:03",
        "description": "Sandu Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. This shift follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, underscoring the complexities faced by the stock in recent periods."
      },
      {
        "title": "Sandu Pharmaceuticals Falls to 52-Week Low of Rs.37.01 Amidst Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sandu-pharmaceuticals-stock-falls-to-52-week-low-of-rs3701-3735027",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SanduPharmaceut_priceRelatedfactors_3735027.png",
        "date": "2025-11-28 09:48:44",
        "description": "Sandu Pharmaceuticals has reached a new 52-week low of Rs.37.01 today, marking a significant decline in its stock price amid broader market activity. The stock’s performance contrasts with the overall positive trend in the Sensex, highlighting ongoing challenges within the company’s financial and operational metrics."
      }
    ],
    "total": 85,
    "sid": "764862",
    "stock_news_url": "https://www.marketsmojo.com/news/sandu-pharmaceuticals-764862"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Feb-2026",
      "details": "Newspaper Publication inrespect of Unaudited Financials for the Q ended 31.12.2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Feb-2026",
      "details": "Newspaper publication inrespect of opening of special window for transfer and dematerialisation of shares",
      "source": "BSE"
    },
    {
      "caption": "Statement Of Deviation And Variation For The Q Ended 31.12.2025",
      "datetime": "06-Feb-2026",
      "details": "Statement of Deviation and Variation for the Q ended 31.12.2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sandu Pharmaceuticals Ltd has declared <strong>8%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Sandu Pharmaceuticals Ltd falling/rising?

2026-02-10 00:13:22

Recent Price Movement and Volatility

Sandu Pharmaceuticals opened the trading session with a gap up of 3.52%, signalling early buying interest. Throughout the day, the stock exhibited high volatility, with an intraday price range of ₹4.06 and a peak intraday high of ₹37.96, representing a 12.24% surge from the previous close. Despite this wide trading range, the weighted average price indicates that a larger volume of shares exchanged hands closer to the lower end of the day’s price spectrum, suggesting some profit-taking or cautious trading among investors.

The stock’s intraday volatility, calculated at 5.65%, underscores the heightened price fluctuations experienced during the session. This level of volatility is significant for a pharmaceutical stock and may reflect...

Read full news article

Sandu Pharmaceuticals Ltd is Rated Strong Sell

2026-02-07 10:10:19

Sandu Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 September 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Sandu Pharmaceuticals Ltd Falls to 52-Week Low of Rs.35.11

2026-01-21 12:15:24

Sandu Pharmaceuticals Ltd has reached a new 52-week low of Rs.35.11, marking a significant decline amid broader market pressures and company-specific performance issues. The stock has underperformed its sector and benchmark indices, reflecting ongoing challenges in growth and profitability metrics.

Read full news article

Sandu Pharmaceuticals Ltd Falls to 52-Week Low Amid Continued Underperformance

2026-01-21 12:14:55

Sandu Pharmaceuticals Ltd’s stock declined to a fresh 52-week low of Rs.35.8 on 21 Jan 2026, marking a significant milestone in its ongoing downward trajectory. The stock has underperformed both its sector and broader market indices, reflecting persistent challenges in its financial and market performance.

Read full news article

Sandu Pharmaceuticals Ltd is Rated Strong Sell

2026-01-15 10:10:03

Sandu Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 September 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Sandu Pharmaceuticals Ltd is Rated Strong Sell

2025-12-26 15:12:03

Sandu Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 September 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 December 2025, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Sandu Pharmaceuticals Falls to 52-Week Low of Rs.36.76 Amidst Continued Underperformance

2025-12-11 10:00:18

Sandu Pharmaceuticals has reached a new 52-week low of Rs.36.76, marking a significant decline in its stock price amid ongoing challenges in its financial performance and market positioning within the Pharmaceuticals & Biotechnology sector.

Read full news article

Sandu Pharma. Sees Revision in Market Evaluation Amidst Challenging Fundamentals

2025-12-07 10:10:03

Sandu Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. This shift follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, underscoring the complexities faced by the stock in recent periods.

Read full news article

Sandu Pharmaceuticals Falls to 52-Week Low of Rs.37.01 Amidst Market Pressure

2025-11-28 09:48:44

Sandu Pharmaceuticals has reached a new 52-week low of Rs.37.01 today, marking a significant decline in its stock price amid broader market activity. The stock’s performance contrasts with the overall positive trend in the Sensex, highlighting ongoing challenges within the company’s financial and operational metrics.